Pharma Industry
Industry: Email Alert RSS FeedKing, Acura in partnership for developing pain treatments
Chain Drug Review, Nov 19, 2007
King Pharmaceuticals Inc. has entered into an agreement with Acura Pharmaceuticals Inc. to develop painkillers using the latter's Aversion technology. King will make an up-front cash payment to Acura of $30 million. King could be responsible for $28 million in additional payments to Acura pending achievement of certain milestones.
Most RecentPharma Articles
- How Gloucester Achieved the Impossible Even Before Inking the Celgene Deal
- Solvay's Alleged Off-Label Switcheroo: 2 Legit Indications Reversed
- Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty
- AstraZeneca's New Depression Drug Is a Cancelled Blood Pressure Medicine
- Europeans Inspect Fewer Than 19 Chinese Drug Factories a Year
- More »
COPYRIGHT 2007 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Make running easier: with this unique 'pose running' technique, you'll learn to actually enjoy your fat-burning sessions
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
Most Popular Health Publications
Content provided in partnership with
Presented by American Express